1. Home
  2. LARK vs NKTR Comparison

LARK vs NKTR Comparison

Compare LARK & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LARK
  • NKTR
  • Stock Information
  • Founded
  • LARK 1885
  • NKTR 1990
  • Country
  • LARK United States
  • NKTR United States
  • Employees
  • LARK N/A
  • NKTR N/A
  • Industry
  • LARK Major Banks
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • LARK Finance
  • NKTR Health Care
  • Exchange
  • LARK Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • LARK 135.9M
  • NKTR 160.4M
  • IPO Year
  • LARK N/A
  • NKTR 1994
  • Fundamental
  • Price
  • LARK $27.73
  • NKTR $0.64
  • Analyst Decision
  • LARK
  • NKTR Strong Buy
  • Analyst Count
  • LARK 0
  • NKTR 6
  • Target Price
  • LARK N/A
  • NKTR $4.92
  • AVG Volume (30 Days)
  • LARK 27.0K
  • NKTR 2.8M
  • Earning Date
  • LARK 04-30-2025
  • NKTR 05-08-2025
  • Dividend Yield
  • LARK 3.01%
  • NKTR N/A
  • EPS Growth
  • LARK 6.15
  • NKTR N/A
  • EPS
  • LARK 2.26
  • NKTR N/A
  • Revenue
  • LARK $58,168,000.00
  • NKTR $98,427,000.00
  • Revenue This Year
  • LARK N/A
  • NKTR N/A
  • Revenue Next Year
  • LARK N/A
  • NKTR N/A
  • P/E Ratio
  • LARK $12.28
  • NKTR N/A
  • Revenue Growth
  • LARK 3.55
  • NKTR 9.21
  • 52 Week Low
  • LARK $17.05
  • NKTR $0.43
  • 52 Week High
  • LARK $28.55
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • LARK 59.79
  • NKTR 45.85
  • Support Level
  • LARK $25.61
  • NKTR $0.43
  • Resistance Level
  • LARK $28.40
  • NKTR $0.68
  • Average True Range (ATR)
  • LARK 1.25
  • NKTR 0.08
  • MACD
  • LARK -0.08
  • NKTR 0.01
  • Stochastic Oscillator
  • LARK 76.82
  • NKTR 72.41

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The bank is principally engaged in the business of attracting deposits from the general public and using such deposits, together with borrowings and other funds, to originate one-to-four-family residential real estate, construction and land, commercial real estate, commercial, agriculture, municipal and consumer loans. In addition, it also invests in certain investment and mortgage related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: